Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and Its N-acetyl Metabolite
Clinical trial NCT01480609 · COMPLETED
Trial details
- NCT number
- NCT01480609
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-30
- Primary completion
- 2012-04-24
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.